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Methods
Eighteen MPS patients (mean age = 13 yr-old, from 5 to 32 years) in enzyme replacement therapy (ERT), 88% male were evaluated (type I = 5, type II = 9 and type VI = 4) by measurement of complete blood count (CBC) and quantitative/ qualitative serum immunoglobulins (Ig; G, M and A) and review of their immunization schedules (BCG, hepatitis B and rubella).
Results
All patients had previous history of wheezing and pneumonia that had significant improvement after initiation of ERT. Only one patient had iron deficiency anemia. Two patients had neutrophils lower than expected and all patients had adequate number of lymphocytes. All patients were vaccinated for BCG, however one patient had lymphnode tuberculosis. Only one patient had IgG serum levels lower than 3 rd percentile. Three patients had IgM levels 3 rd lower percentile. Despite complete hepatitis B vaccination schedule, 10 (55%) patients showed absence of response to vaccine; and 1 patient (5.5%) showed no response to rubella vaccine .
Conclusions
The immunological evaluation of MPS patients is mandatory, especially for the high frequency of respiratory infections presented by them. More studies on the humoral and innate immunity are needed to understand the disease and improve the treatment of these complications.
